Skip to main content
OpenTrials

Clinical trial condition

Myelodysplastic Syndrome

Explore clinical trials studying Myelodysplastic Syndrome. Study availability and eligibility vary by location and protocol.

431 public trials 64 recruiting studies
Refine in advanced search Browse all conditions

Myelodysplastic Syndrome trial results

Completed

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

NCT02296242

Conditions
Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • UCLA Medical Center Los Angeles, California, United States
  • Winship Cancer Institute of Emory University Atlanta, Georgia, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Multiple Dose, Dose Escalation Trial of AEB1102 in Patients With AML or MDS

NCT02732184

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations
  • Comprehensive Cancer Center at University of Michigan Ann Arbor, Michigan, United States
  • Washington University Medical School St Louis, Missouri, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
  • The Cleveland Clinic Cleveland, Ohio, United States
View Trial Details
Completed

Phase 2 Study of Pracinostat With Azacitidine in Patients With Previously Untreated Myelodysplastic Syndrome

NCT01873703

Conditions
Bone Marrow Diseases, Hematologic Diseases, Hemic and Lymphatic Diseases, +2 more
Locations
  • Southern Cancer Center Mobile, Alabama, United States
  • Scripps Cancer Center La Jolla, California, United States
  • Colorado Blood Cancer Institute Denver, Colorado, United States
  • Florida Cancer Specialists South Fort Myers, Florida, United States
View all 24 locations
View Trial Details

Related conditions